[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zou et al., 2011 - Google Patents

p57Kip2 and p27Kip1 cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70

Zou et al., 2011

View HTML @Full View
Document ID
6732116448389113230
Author
Zou P
Yoshihara H
Hosokawa K
Tai I
Shinmyozu K
Tsukahara F
Maru Y
Nakayama K
Nakayama K
Suda T
Publication year
Publication venue
Cell stem cell

External Links

Snippet

Cell cycle regulators play critical roles in the balance between hematopoietic stem cell (HSC) dormancy and proliferation. In this study, we report that cell cycle entry proceeded normally in HSCs null for cyclin-dependent kinase (CDK) inhibitor p57 due to compensatory …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Zou et al. p57Kip2 and p27Kip1 cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70
de Almeida et al. Dye-independent methods reveal elevated mitochondrial mass in hematopoietic stem cells
Volk et al. A CHAF1B-dependent molecular switch in hematopoiesis and leukemia pathogenesis
Tomellini et al. Integrin-α3 is a functional marker of ex vivo expanded human long-term hematopoietic stem cells
Hur et al. CD82/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages
Liu et al. p53 regulates hematopoietic stem cell quiescence
Luo et al. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence
Lu et al. Polycomb group protein YY1 is an essential regulator of hematopoietic stem cell quiescence
Takubo et al. Regulation of the HIF-1α level is essential for hematopoietic stem cells
Matsumoto et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells
Liang et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue
Luchsinger et al. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential
King et al. The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells
Moriggl et al. Stat5 tetramer formation is associated with leukemogenesis
Rouault-Pierre et al. HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress
Van Nguyen et al. SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation
Galan-Caridad et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells
Renström et al. Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells
Zhao et al. Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo
Jude et al. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors
Jones et al. Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells
Nakagawa et al. Constitutive activation of the canonical NF-κB pathway leads to bone marrow failure and induction of erythroid signature in hematopoietic stem cells
Kim et al. Identification of a stroma-mediated Wnt/β-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche
Sirin et al. The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells
Schreck et al. Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cells